全文获取类型
收费全文 | 7832篇 |
免费 | 373篇 |
国内免费 | 60篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 191篇 |
妇产科学 | 293篇 |
基础医学 | 833篇 |
口腔科学 | 115篇 |
临床医学 | 753篇 |
内科学 | 2056篇 |
皮肤病学 | 110篇 |
神经病学 | 921篇 |
特种医学 | 244篇 |
外科学 | 1150篇 |
综合类 | 25篇 |
预防医学 | 360篇 |
眼科学 | 193篇 |
药学 | 467篇 |
中国医学 | 17篇 |
肿瘤学 | 482篇 |
出版年
2023年 | 48篇 |
2022年 | 88篇 |
2021年 | 175篇 |
2020年 | 122篇 |
2019年 | 146篇 |
2018年 | 170篇 |
2017年 | 141篇 |
2016年 | 167篇 |
2015年 | 198篇 |
2014年 | 261篇 |
2013年 | 341篇 |
2012年 | 527篇 |
2011年 | 539篇 |
2010年 | 300篇 |
2009年 | 334篇 |
2008年 | 527篇 |
2007年 | 573篇 |
2006年 | 574篇 |
2005年 | 484篇 |
2004年 | 437篇 |
2003年 | 335篇 |
2002年 | 337篇 |
2001年 | 103篇 |
2000年 | 100篇 |
1999年 | 90篇 |
1998年 | 80篇 |
1997年 | 67篇 |
1996年 | 64篇 |
1995年 | 41篇 |
1994年 | 36篇 |
1993年 | 62篇 |
1992年 | 112篇 |
1991年 | 58篇 |
1990年 | 80篇 |
1989年 | 67篇 |
1988年 | 60篇 |
1987年 | 49篇 |
1986年 | 44篇 |
1985年 | 39篇 |
1984年 | 58篇 |
1983年 | 31篇 |
1982年 | 23篇 |
1981年 | 27篇 |
1980年 | 16篇 |
1979年 | 22篇 |
1978年 | 15篇 |
1977年 | 10篇 |
1975年 | 8篇 |
1974年 | 11篇 |
1972年 | 7篇 |
排序方式: 共有8265条查询结果,搜索用时 15 毫秒
31.
32.
33.
34.
35.
36.
New Insights into the Pathogenesis and the Therapy of Recurrent Focal Glomerulosclerosis 总被引:4,自引:0,他引:4
Recurrent focal glomerulosclerosis (FSGS) in renal allografts has remained a frustrating and enigmatic disease. Recent studies on gene mutations encoding podocin and other components of the slit-diaphragm in patients with native kidney nephrotic syndrome have underscored the heterogenecity of the idiopathic form of FSGS. While familial FSGS rarely recurs following transplantation, the sporadic variety of FSGS is associated with a 30% recurrence rate. The patients with the sporadic variety of FSGS who have homozygous or complex heterozygous podocin mutations have a low recurrence rate. In the other patients with sporadic FSGS, a more complex and likely multifactorial etiology accounts for the recurrence of FSGS. The role of CD80 expression on podocytes is intriguing but requires confirmation in kidney biopsies of patients with recurrent FSGS. Recent findings on podocin genomics, the permeability factor and CD80 expression may ultimately lead to a better understanding of recurrent FSGS as well as a more effective approach to its prevention and treatment. 相似文献
37.
38.
Antonio Bobbio Alfredo Chetta Luca Ampollini Gian Luca Primomo Eveline Internullo Paolo Carbognani Michele Rusca Dario Olivieri 《European journal of cardio-thoracic surgery》2008,33(1):95-98
BACKGROUND: The impact of short-term preoperative pulmonary rehabilitation on exercise capacity of patients with chronic obstructive pulmonary disease undergoing lobectomy for non-small cell lung cancer is evaluated. METHODS: A prospective observational study was designed. Inclusion criteria consisted of an indication to lung resection because of a clinical stage I or II non-small cell lung cancer and a chronic obstructive disease on preoperative pulmonary function test. In such conditions, maximal oxygen consumption by a cardio-pulmonary exercise test was evaluated; when this resulted as being < or =15 ml/kg/min a pulmonary rehabilitation programme lasting 4 weeks was considered. Twelve patients fulfilled inclusion criteria, completed the preoperative rehabilitation programme and underwent a new functional evaluation prior to surgery. The postoperative record of these patients was collected. RESULTS: On completion of pulmonary rehabilitation, the resting pulmonary function test and diffuse lung capacity of patients was unchanged, whereas the exercise performance was found to have significantly improved; the mean increase in maximal oxygen consumption proved to be at 2.8 ml/kg/min (p<0.01). Eleven patients underwent lobectomy; no postoperative mortality was noted and mean hospital stay was 17 days. Postoperative pulmonary complication was recorded in 8 patients. CONCLUSIONS: Short-term preoperative pulmonary rehabilitation could improve the exercise capacity of patients with chronic obstructive pulmonary disease who are candidates for lung resection for non-small cell lung cancer. 相似文献
39.
Fabio Piscaglia Valeria Camaggi Matteo Ravaioli Gian Luca Grazi Matteo Zanello Simona Leoni Giorgio Ballardini Giulia Cavrini Antonio Daniele Pinna Luigi Bolondi 《Liver transplantation》2007,13(6):857-866
The best prioritization of patients with hepatocellular carcinoma (HCC) waiting for liver transplantation under the model for end-stage liver disease (MELD) allocation system is still being debated. We analyzed the impact of a MELD adjustment for HCC, which consisted of the addition of an extra score (based on the HCC stage and waiting time) to the native MELD score. The outcome was analyzed for 301 patients with chronic liver disease listed for liver transplantation between March 1, 2001 and February 28, 2003 [United Network for Organ Sharing (UNOS)-Child-Turcotte-Pugh (CTP) era, 163 patients, 28.8% with HCC] and between March 1, 2003 and February 28, 2004 (HCC-MELD era, 138 patients, 29.7% with HCC). In the HCC-MELD era, the cumulative dropout risk at 6 months was 17.6% for patients with HCC versus 22.3% for those patients without HCC (P = NS), similar to that in the UNOS-CTP era. The cumulative probability of transplantation at 6 months was 70.3% versus 39.0% (P = 0.005), being higher than that in the UNOS-CTP era for patients with HCC (P = 0.02). At the end of the HCC-MELD era, 12 patients with HCC (29.3%) versus 57 without HCC (58.8%) were still on the list (P = 0.001). Both native and adjusted MELD scores were higher (P < 0.05) and progressed more in patients with HCC who dropped out than in those who underwent transplantation or remained on the list (the initial-final native MELD scores were 17.3-23.1, 15.5-15.6, and 12.8-14.1, respectively). The patients without HCC remaining on the list showed stable MELD scores (initial-final: 15.1-15.4). In conclusion, the present data support the strategy of including the native MELD scores in the allocation system for HCC. This model allows the timely transplantation of patients with HCC without severely affecting the outcome of patients without HCC. 相似文献
40.